These findings elucidate the role of oxytocin in the pathophysiology of schizophrenia and have inspired growing research on the therapeutic potential of exogenous oxytocin; some clinical trials have reported encouraging results22,23, but the overall findings have been inconsistent. This evidence concerns the gene OXT and schizophrenia.